GoodRx Holdings, Inc. (GDRX) Free cash flow 2018–2025
GoodRx Holdings, Inc. (GDRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$164.4MFY2025 · since FY2018: $44.4M → $164.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $164.4M | -10.0% |
| FY2024 | $182.7M | +33.1% |
| FY2023 | $137.2M | -3.9% |
| FY2022 | $142.8M | -18.0% |
| FY2021 | $174.2M | +57.2% |
| FY2020 | $110.8M | +35.3% |
| FY2019 | $81.9M | +84.2% |
| FY2018 | $44.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GDRX financial trends
GDRX RevenueGDRX Net incomeGDRX Net marginGDRX Gross profitGDRX Gross marginGDRX Operating incomeGDRX Operating marginGDRX Operating cash flowGDRX Capital expendituresGDRX Return on equityGDRX Stock buybacksGDRX Dividends paidGDRX Total assetsGDRX Total liabilitiesGDRX Shareholders’ equityGDRX overview →